Bajrami, I., Frankum, J. R., Konde, A., Miller, R. E., Rehman, F. L., Brough, R., . . . Ashworth, A. (2013). Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity. Cancer Res.
シカゴスタイル引用形Bajrami, Ilirjana, et al. "Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 As a Novel Determinant of PARP1/2 Inhibitor Sensitivity." Cancer Res 2013.
MLA引用形式Bajrami, Ilirjana, et al. "Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 As a Novel Determinant of PARP1/2 Inhibitor Sensitivity." Cancer Res 2013.
警告: この引用は必ずしも正確ではありません.